Skip to main content

Consultation: Proposed minor changes to Required Advisory Statements for Medicine Labels (RASML): Chlorhexidine, hydrocortisone, ibuprofen

Consultation period
-
Last updated

Help us improve the Therapeutic Goods Administration site